Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY (DEFICIT)

v3.22.4
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Warrants
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2019 43,836,109          
Beginning balance at Dec. 31, 2019 $ 151,938          
Ending Balance (in shares) at Dec. 31, 2020 43,836,109          
Beginning balance at Dec. 31, 2020 $ 151,938          
Beginning balance (in shares) at Dec. 31, 2019   10,816,231        
Beginning balance at Dec. 31, 2019 (85,990) $ 0   $ 3,797 $ (89,787) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)   1,066,055        
Issuance of common shares from stock option exercises 851     851    
Stock-based compensation 11,613     11,613    
Foreign currency translation adjustments, net of tax 2         2
Net unrealized gain on investments 0          
Net loss (40,421)       (40,421)  
Ending balance (in shares) at Dec. 31, 2020   11,882,286        
Ending balance at Dec. 31, 2020 $ (113,945) $ 0   16,261 (130,208) 2
Redeemable Convertible            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (43,836,109)          
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (151,938)          
Ending Balance (in shares) at Dec. 31, 2021 0          
Beginning balance at Dec. 31, 2021 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)   3,501,964        
Issuance of common shares from stock option exercises 4,166     4,166    
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)   43,836,109 104,269      
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 151,938     151,938    
Issuance of common stock in connection with initial public offering, net of underwriting discounts (in shares)   5,000,000        
Issuance of common stock in connection with initial public offering, net of underwriting discounts 111,600     111,600    
Offering costs (3,826)     (3,826)    
Stock-based compensation 14,091     14,091    
Foreign currency translation adjustments, net of tax (33)         (33)
Net unrealized gain on investments 0          
Net loss $ (51,690)       (51,690)  
Ending balance (in shares) at Dec. 31, 2021 64,324,628 64,324,628        
Ending balance at Dec. 31, 2021 $ 112,301 $ 0   294,230 (181,898) (31)
Ending Balance (in shares) at Dec. 31, 2022 0          
Beginning balance at Dec. 31, 2022 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares) 1,069,935 1,069,935        
Issuance of common shares from stock option exercises $ 1,315     1,315    
Issuance of common shares from the employee stock purchase plan (in shares)   165,347        
Issuance of common shares from the employee stock purchase plan 858     858    
Offering costs (271)     (271)    
Vesting of restricted stock units (in shares)   179,143        
Stock-based compensation 18,752     18,752    
Foreign currency translation adjustments, net of tax (10)         (10)
Net unrealized gain on investments 12         12
Net loss $ (49,738)       (49,738)  
Ending balance (in shares) at Dec. 31, 2022 65,739,053 65,739,053        
Ending balance at Dec. 31, 2022 $ 83,219 $ 0   $ 314,884 $ (231,636) $ (29)